Rituxan and Back spasm - a phase IV clinical study of FDA data
Summary:
We study 64,813 people who take Rituxan (rituximab) or have Back spasm. No report of Back spasm is found in people who take Rituxan.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Rituxan?
Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 64,790 Rituxan users. Check the latest studies of Rituxan.
What is Back Spasm?
Back spasm: no further information found. Check the latest studies of Back spasm.
No report is found.
Do you take Rituxan and have Back spasm?
- Check whether Back spasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Rituxan:
- Rituxan (64,790 reports)
Back spasm treatments and more:
- Back spasm (23 reports)
How severe was Back spasm and when was it recovered:
Expand to all the drugs that have ingredients of rituximab:
Browse all side effects of Rituxan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Back spasm:
Browse all the conditions that are associated with Back spasm:
How the study uses the data?
The study uses data from the FDA. It is based on rituximab (the active ingredients of Rituxan) and Rituxan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Efavirenz cause Hepatotoxicity? - 7 seconds ago
- Blood Alkaline Phosphatase Decreased and drugs of ingredients of tacrolimus - 12 seconds ago
- Drug interactions of Dexedrine and Fosamax - 15 seconds ago
- Could Temazepam cause Rhinovirus Infection? - 18 seconds ago
- Tenormin and Dyspnea Exacerbated for Men aged 40-49 - 19 seconds ago
- Tenormin and Dyspnoea Exacerbated for Men aged 40-49 - 19 seconds ago
- Strattera and Deep Vein Thrombosis for Women aged 50-59 - 20 seconds ago
- Strattera and Dvt for Women aged 50-59 - 20 seconds ago
- Strattera and Blood Clot In The Legs for Women aged 50-59 - 20 seconds ago
- Strattera and Deep Venous Thrombosis for Women aged 50-59 - 21 seconds ago